These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30450521)

  • 1. Effect of Vasopressin V1b Receptor Blockade on Activity of the Hypothalamic-Pituitary-Adrenal Axis in Old Monkeys with Depression-Like and Anxious Behavior Subjected to Stress or Injected with Vasopressin.
    Goncharova ND; Chigarova OA; Oganyan TE
    Bull Exp Biol Med; 2018 Nov; 166(1):86-91. PubMed ID: 30450521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.
    Katz DA; Liu W; Locke C; Dutta S; Tracy KA
    Psychopharmacology (Berl); 2016 Jan; 233(1):71-81. PubMed ID: 26407603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific and individual features of vasopressinergic regulation of the hypothalamic-pituitary-adrenal system in primates.
    Goncharova ND; Oganyan TE; Marenin VY; Vengerin AA
    Bull Exp Biol Med; 2015 Apr; 158(6):804-6. PubMed ID: 25894781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.
    Tanoue A; Ito S; Honda K; Oshikawa S; Kitagawa Y; Koshimizu TA; Mori T; Tsujimoto G
    J Clin Invest; 2004 Jan; 113(2):302-9. PubMed ID: 14722621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior.
    Hodgson RA; Mullins D; Lu SX; Guzzi M; Zhang X; Bleickardt CJ; Scott JD; Miller MW; Stamford AW; Parker EM; Varty GB
    Eur J Pharmacol; 2014 May; 730():157-63. PubMed ID: 24602808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation.
    Aguilera G; Rabadan-Diehl C
    Regul Pept; 2000 Dec; 96(1-2):23-9. PubMed ID: 11102648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms.
    Newson MJ; Roberts EM; Pope GR; Lolait SJ; O'Carroll AM
    J Endocrinol; 2009 Jul; 202(1):123-9. PubMed ID: 19395447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related differences in stress responsiveness of the hypothalamic-pituitary-adrenal axis of nonhuman primates with various types of adaptive behavior.
    Goncharova ND; Oganyan TE
    Gen Comp Endocrinol; 2018 Mar; 258():163-172. PubMed ID: 28789856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
    Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress.
    Chen J; Young S; Subburaju S; Sheppard J; Kiss A; Atkinson H; Wood S; Lightman S; Serradeil-Le Gal C; Aguilera G
    Ann N Y Acad Sci; 2008 Dec; 1148():349-59. PubMed ID: 19120128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism.
    Heida JE; Minović I; van Faassen M; Kema IP; Boertien WE; Bakker SJL; van Beek AP; Gansevoort RT
    Am J Nephrol; 2020; 51(11):861-870. PubMed ID: 33147589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Stress-Induced ACTH Secretion by Vasopressin and CRH: Additional Evidence.
    Ramos AT; Tufik S; Troncone LR
    Neuropsychobiology; 2016; 73(3):184-90. PubMed ID: 27221315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress.
    Jasnic N; Djordjevic J; Vujovic P; Lakic I; Djurasevic S; Cvijic G
    J Exp Biol; 2013 Jun; 216(Pt 12):2302-7. PubMed ID: 23580725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of the Hypothalamic-Pituitary-Adrenal System to Repeated Moderate Psychoemotional Stress Exposure Is Associated with Behavioral Parameters.
    Goncharova ND; Chigarova OA; Oganyan TE
    Bull Exp Biol Med; 2017 May; 163(1):95-98. PubMed ID: 28577092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress.
    Welt T; Engelmann M; Renner U; Erhardt A; Müller MB; Landgraf R; Holsboer F; Keck ME
    Neuropsychopharmacology; 2006 Dec; 31(12):2573-9. PubMed ID: 16395302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin V1B Receptor Antagonists as Potential Antidepressants.
    Chaki S
    Int J Neuropsychopharmacol; 2021 Jul; 24(6):450-463. PubMed ID: 33733667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist.
    Roper JA; Craighead M; O'Carroll AM; Lolait SJ
    J Neuroendocrinol; 2010 Nov; 22(11):1173-80. PubMed ID: 20846299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel and selective V1B receptor antagonist.
    Craighead M; Milne R; Campbell-Wan L; Watson L; Presland J; Thomson FJ; Marston HM; Macsweeney CP
    Prog Brain Res; 2008; 170():527-35. PubMed ID: 18655906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.
    Spiga F; Harrison LR; Wood S; Knight DM; MacSweeney CP; Thomson F; Craighead M; Lightman SL
    J Endocrinol; 2009 Mar; 200(3):273-83. PubMed ID: 19008333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.